ReachRxResearch
Home
Research
Sign Up
Lipoprotein(a) and Incident Venous Thromboembolism
Back to Research Hub
  1. Home
  2. Research Hub
  3. Lipoprotein(a) and Incident Venous Throm…

Lipoprotein(a) and Incident Venous Thromboembolism

JAMA Cardiology·September 23Open Access
Cardiac & Cardiovascular SystemsLimited evidenceVenous ThromboembolismCohort StudyLipoprotein(A) Measurement

Summary

View source

What was studied

This cohort study evaluated the association between measured lipoprotein(a) [Lp(a)] levels and the risk of incident venous thromboembolism (VTE).

Study limitations

The full text is not publicly available (embargoed until 2027-09-23), so specific results, sample size, follow-up duration, and methodological details cannot be assessed.

Caveats

  • No abstract with results was available, so key findings, population characteristics, and study limitations could not be verified or summarized
  • Prior evidence on Lp(a) and VTE is conflicting (some meta-analyses show association; at least one large study and a Mendelian randomization study do not), so conclusions from this study should be interpreted in that context once full data are accessible
  • The full text of this article is not publicly available (PMC embargo until 2027-09-23); all extractable information is limited to the plain-language summary and publisher page metadata — specific results, sample size, effect sizes, and methodological details are unknown

Related Questions

Explore related topics

What is the association between lipoprotein(a) levels and venous thromboembolism risk?Does elevated Lp(a) independently predict DVT or pulmonary embolism in clinical cohorts?Are there medications that lower Lp(a) and reduce VTE risk?

Publication Details

Year
2026
Journal
JAMA Cardiology
Source
View article
Keep scrolling
More content below.
Up Next